Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon P Kim

Showing results (91-100 of 211) with videos related to

Pageof 22
Sort By:
Urology|July 11, 2018
Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate CancerAlbert H Kim, Badrinath Konety, Zhengyi Chen, et al.
Urologic Oncology|April 28, 2024
Cost of upper tract imaging obtained during hematuria evaluation: Analysis of a national claims databaseAlex Hannemann, Rodrigo Rodrigues Pessoa, Thomas Flaig, et al.
European Urology|March 21, 2016
Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy ComplicationsBoris Gershman, Holly K Van Houten, Jeph Herrin, et al.
European Urology|January 26, 2017
Corrigendum re: "Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications" [Eur Urol 2017;71:55-65]Boris Gershman, Holly K Van Houten, Jeph Herrin, et al.
European Urology|April 26, 2011
Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal glandChristopher J Weight, Simon P Kim, Christine M Lohse, et al.
European Journal of Cancer Care|October 28, 2020
Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national surveyKang Puneet, Jon C Tilburt, Robert J Volk, et al.
European Urology|December 19, 2016
Collaborative Review of Risk Benefit Trade-offs Between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal MassesSimon P Kim, Steven C Campbell, Inderbir Gill, et al.
Urologic Oncology|October 9, 2019
Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification modelOsama Al-Alao, Catrina Mueller-Leonhard, Simon P Kim, et al.
The Journal of Urology|January 15, 2013
Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancerStephen A Boorjian, Simon P Kim, Matthew K Tollefson, et al.
European Urology Focus|October 27, 2018
The Association of Robot-assisted Versus Pure Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Hospital CostsBoris Gershman, Laura Bukavina, Zhengyi Chen, et al.
Pageof 22

Showing results (91-100 of 211) with videos related to

Sort By:
Pageof 22
Urology|July 11, 2018
Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate CancerAlbert H Kim, Badrinath Konety, Zhengyi Chen, et al.
Urologic Oncology|April 28, 2024
Cost of upper tract imaging obtained during hematuria evaluation: Analysis of a national claims databaseAlex Hannemann, Rodrigo Rodrigues Pessoa, Thomas Flaig, et al.
European Urology|March 21, 2016
Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy ComplicationsBoris Gershman, Holly K Van Houten, Jeph Herrin, et al.
European Urology|January 26, 2017
Corrigendum re: "Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications" [Eur Urol 2017;71:55-65]Boris Gershman, Holly K Van Houten, Jeph Herrin, et al.
European Urology|April 26, 2011
Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal glandChristopher J Weight, Simon P Kim, Christine M Lohse, et al.
European Journal of Cancer Care|October 28, 2020
Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national surveyKang Puneet, Jon C Tilburt, Robert J Volk, et al.
European Urology|December 19, 2016
Collaborative Review of Risk Benefit Trade-offs Between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal MassesSimon P Kim, Steven C Campbell, Inderbir Gill, et al.
Urologic Oncology|October 9, 2019
Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification modelOsama Al-Alao, Catrina Mueller-Leonhard, Simon P Kim, et al.
The Journal of Urology|January 15, 2013
Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancerStephen A Boorjian, Simon P Kim, Matthew K Tollefson, et al.
European Urology Focus|October 27, 2018
The Association of Robot-assisted Versus Pure Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Hospital CostsBoris Gershman, Laura Bukavina, Zhengyi Chen, et al.
Pageof 22